[1] 杨光,杨亮,包木胜,等. 新型CpGODN对乙型肝炎病毒复制的抑制作用[J]. 中国免疫学杂志,2009,(7):60-63. [2] CHEN J,XU W,ZHOU T,et al. Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development [J]. Parasite Immunol,2009,31(8):466-473. [3] BERTIN S,ANJUERE F,GAVELLI A,et al. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model[J]. Int J Mol Med,2008,21(3):309-315. [4] 严茂林,王耀东,田毅峰,等. 小鼠肝Kupffer细胞分离方法探讨[J]. 福建医科大学学报,2008,42(6):526-528. [5] 王郁杰. pCMV-tag2B—HBX质粒的构建和表达[J]. 内科,2008,3(3):326-328. [6] 孙长宇,张贤强,杨观瑞,等. HBX蛋白、骨桥蛋白、基质金属蛋白酶-9在肝细胞癌组织中的表达及意义[J]. 山东医药,2008,48(48):6-8. [7] 董宁,姚咏明. Toll 样受体免疫学研究新进展[J]. 感染炎症修复,2008,9(3):34-36. [8] SHARMA S,DOMINGGUEZ AL,MANRIQUE SZ,et al. Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice[J]. Cancer Res,2008,68(18):7530-7540. [9] KAWABATA T,KINOSHITA M,INATSU A,et al. Functional alterations of liver innate immunity of mice with aging in response to CpG-oligodeoxynucleotide[J]. Hepatology,2008,48(5):1586-1597. [10] VAN DER BIJ GJ,OOSTERLING SJ,MEIJER S,et al. Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth[J]. Immunobiology,2005,210(2-4):259-265. [11] OHATA K,ICHIKAWA T,NAKAO K,et al. Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells[J]. FEBS Lett,2003,553(3):304-308. |